Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.
BörsenkürzelCERT
Name des UnternehmensCertara Inc
IPO-datumDec 11, 2020
CEOFeehery (William F)
Anzahl der mitarbeiter1487
WertpapierartOrdinary Share
GeschäftsjahresendeDec 11
Addresse4 Radnor Corporate Center, Suite 350
StadtRADNOR
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl19087
Telefon14152378272
Websitehttps://www.certara.com/
BörsenkürzelCERT
IPO-datumDec 11, 2020
CEOFeehery (William F)
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten